SOT Annual Meeting: March 10 – 14, 2019
ToxExpo: March 11 – 13, 2019
Baltimore Convention Center, Baltimore, MD
High attrition rates in clinical trials is an indication that current testing is failing to predict safety/efficacy of compounds. NeuCyte supports the early phases of drug discovery programs as well as the investigation of MOAs for experimental compounds. Based on the SynFire® technology, our human neural invitro platforms are uniquely suited for assessing relevant higher order electrophysiology readouts which allow for a better predictor of drug efficacy and potential CNS Safety/Toxicology.
@ToxExpo on Twitter
Exhibit Space and Rates
Request a Booth
Exhibitor Service Center
Baltimore Convention Center
1 W Pratt St
Copyright 2018, a2z, Inc. All rights reserved.